Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 4
2005 2
2006 4
2007 3
2008 3
2009 2
2010 2
2011 1
2012 1
2013 1
2015 1
2016 6
2017 2
2018 12
2019 5
2020 6
2021 11
2022 6
Text availability
Article attribute
Article type
Publication date

Search Results

60 results
Results by year
Filters applied: . Clear all
Page 1
Nomograms to predict outcomes after 177Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer: an international, multicentre, retrospective study.
Gafita A, Calais J, Grogan TR, Hadaschik B, Wang H, Weber M, Sandhu S, Kratochwil C, Esfandiari R, Tauber R, Zeldin A, Rathke H, Armstrong WR, Robertson A, Thin P, D'Alessandria C, Rettig MB, Delpassand ES, Haberkorn U, Elashoff D, Herrmann K, Czernin J, Hofman MS, Fendler WP, Eiber M. Gafita A, et al. Among authors: d alessandria c. Lancet Oncol. 2021 Aug;22(8):1115-1125. doi: 10.1016/S1470-2045(21)00274-6. Epub 2021 Jul 8. Lancet Oncol. 2021. PMID: 34246328 Free article.
Activity and Adverse Events of Actinium-225-PSMA-617 in Advanced Metastatic Castration-resistant Prostate Cancer After Failure of Lutetium-177-PSMA.
Feuerecker B, Tauber R, Knorr K, Heck M, Beheshti A, Seidl C, Bruchertseifer F, Pickhard A, Gafita A, Kratochwil C, Retz M, Gschwend JE, Weber WA, D'Alessandria C, Morgenstern A, Eiber M. Feuerecker B, et al. Among authors: d alessandria c. Eur Urol. 2021 Mar;79(3):343-350. doi: 10.1016/j.eururo.2020.11.013. Epub 2020 Dec 5. Eur Urol. 2021. PMID: 33293081
In silico study on radiobiological efficacy of Ac-225 and Lu-177 for PSMA-guided radiotherapy.
Birindelli G, Drobnjakovic M, Morath V, Steiger K, D'Alessandria C, Gourni E, Afshar-Oromieh A, Weber W, Rominger A, Eiber M, Shi K. Birindelli G, et al. Among authors: d alessandria c. Annu Int Conf IEEE Eng Med Biol Soc. 2021 Nov;2021:4497-4500. doi: 10.1109/EMBC46164.2021.9630297. Annu Int Conf IEEE Eng Med Biol Soc. 2021. PMID: 34892217
New radiopharmaceuticals for imaging rheumatoid arthritis.
Chianelli M, D'Alessandria C, Conti F, Priori R, Valesini G, Annovazzi A, Signore A. Chianelli M, et al. Among authors: d alessandria c. Q J Nucl Med Mol Imaging. 2006 Sep;50(3):217-25. Q J Nucl Med Mol Imaging. 2006. PMID: 16868535 Free article. Review.
Imaging atherosclerotic plaques by targeting Galectin-3 and activated macrophages using (89Zr)-DFO- Galectin3-F(ab')2 mAb.
Varasteh Z, De Rose F, Mohanta S, Li Y, Zhang X, Miritsch B, Scafetta G, Yin C, Sager HB, Glasl S, Gorpas D, Habenicht AJR, Ntziachristos V, Weber WA, Bartolazzi A, Schwaiger M, D'Alessandria C. Varasteh Z, et al. Among authors: d alessandria c. Theranostics. 2021 Jan 1;11(4):1864-1876. doi: 10.7150/thno.50247. eCollection 2021. Theranostics. 2021. PMID: 33408786 Free PMC article.
Modeling and Predicting Tumor Response in Radioligand Therapy.
Kletting P, Thieme A, Eberhardt N, Rinscheid A, D'Alessandria C, Allmann J, Wester HJ, Tauber R, Beer AJ, Glatting G, Eiber M. Kletting P, et al. Among authors: d alessandria c. J Nucl Med. 2019 Jan;60(1):65-70. doi: 10.2967/jnumed.118.210377. Epub 2018 May 10. J Nucl Med. 2019. PMID: 29748236 Free article.
60 results